Chemical activators of Olr804 include a variety of compounds that influence different signaling pathways leading to the functional activation of this protein. Forskolin, known for its ability to directly activate adenylate cyclase, results in an increased production of cAMP within the cell. This rise in cAMP levels further leads to the activation of protein kinase A (PKA), a kinase capable of phosphorylating Olr804, thereby enhancing its activity. Similarly, Isoproterenol, a beta-adrenergic agonist, also elevates cAMP concentrations in cells, which in turn activates PKA, and this activation cascade can culminate in the phosphorylation and activation of Olr804. Another compound, Phorbol 12-myristate 13-acetate (PMA), activates protein kinase C (PKC), which is involved in a multitude of cellular processes; activation of PKC can result in the phosphorylation and subsequent activation of Olr804 as part of its downstream signaling events.
Furthering this activation profile, compounds like Ionomycin and Calcimycin (A23187) increase intracellular calcium levels, which may activate calcium-dependent kinases. These kinases have the potential to phosphorylate and activate Olr804. Calyculin A, by inhibiting protein phosphatases, may lead to a sustained phosphorylated state of proteins, including Olr804, thereby keeping it in an active form. Anisomycin, which activates stress-activated protein kinases (SAPKs), can also contribute to the activation of Olr804 through phosphorylation. Activation of the MAPK/ERK pathway by Epidermal Growth Factor (EGF) is another route through which Olr804 can be phosphorylated and activated. Hydrogen Peroxide, through oxidative signaling, can activate kinases that phosphorylate Olr804. Lithium Chloride, by inhibiting GSK-3, can indirectly influence the Wnt signaling pathway, potentially resulting in the activation of Olr804. Dibutyryl cyclic AMP (db-cAMP) acts as a cAMP analog, activating PKA, which then can activate Olr804. Lastly, Okadaic Acid, a protein phosphatase inhibitor, can lead to a sustained active phosphorylation state of Olr804, ensuring its continuous activation within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Functions as a beta-adrenergic agonist, leading to increased cAMP and subsequent activation of PKA, which can phosphorylate and activate Olr804. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
An activator of protein kinase C (PKC), which can phosphorylate and activate Olr804 as part of its downstream effects. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, potentially activating calcium-dependent kinases that could phosphorylate and activate Olr804. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Also elevates intracellular calcium, which can activate calcium-dependent kinases, and these kinases can then phosphorylate and activate Olr804. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases, potentially leading to a sustained phosphorylated (active) state of Olr804. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases (SAPKs) which could lead to the phosphorylation and activation of Olr804. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Through oxidative modifications, it can lead to the activation of signal transduction pathways that include kinases which can phosphorylate and activate Olr804. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, which could lead to activation of the Wnt signaling pathway, affecting proteins in the pathway, including phosphorylation and activation of Olr804. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Acts as a cAMP analog, potentially leading to activation of PKA and subsequent phosphorylation and activation of Olr804. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases, leading to a sustained phosphorylated state of proteins, which could result in phosphorylation and activation of Olr804. | ||||||